Evidence map›Paper›PMID 30296340›Full record

ArticleRisk analysis : an official publication of the Society for Risk Analysis2019

Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan.

Dominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, Kimberly M Thompson

Open access · greenAbstract read
In one paragraph

Article in Risk analysis : an official publication of the Society for Risk Analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences.Risk analysis : an official publication of the Society for Risk Analysis · 2024
    Review
  4. Article
  5. Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan.Risk analysis : an official publication of the Society for Risk Analysis · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Review
  11. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria.Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Article
  12. Article
  13. Article
  14. Modeling and Managing Poliovirus Risks: We are Where we are….Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Article
  15. Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame.Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Article
  16. Review
  17. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.Risk analysis : an official publication of the Society for Risk Analysis · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dominika A KalkowskaKid Risk, Inc., Columbus, OH, USA.
Radboud J Duintjer TebbensKid Risk, Inc., Columbus, OH, USA.
Mark A PallanschDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kimberly M ThompsonKid Risk, Inc., Columbus, OH, USA.
Columbus Oncology and Hematology Associates · USCenters for Disease Control and Prevention · US

Funding

CGH CDC HHS U2R GH001913U.S. Centers for Disease Control and Prevention, Center for Global Health 5NU2RGH001913-02-00
6 · The paper itself

Abstract

Since most poliovirus infections occur with no paralytic symptoms, the possibility of silent circulation complicates the confirmation of the end of poliovirus transmission. Based on empirical field experience and theoretical modeling results, the Global Polio Eradication Initiative identified three years without observing paralytic cases from wild polioviruses with good acute flaccid paralysis surveillance as an indication of sufficient confidence that poliovirus circulation stopped. The complexities of real populations and the imperfect nature of real surveillance systems subsequently demonstrated the importance of specific modeling for areas at high risk of undetected circulation, resulting in varying periods of time required to obtain the same level of confidence about no undetected circulation. Using a poliovirus transmission model that accounts for variability in transmissibility and neurovirulence for different poliovirus serotypes and characterizes country-specific factors (e.g., vaccination and surveillance activities, demographics) related to wild and vaccine-derived poliovirus transmission in Pakistan and Afghanistan, we consider the probability of undetected poliovirus circulation for those countries once apparent die-out occurs (i.e., in the absence of any epidemiological signals). We find that gaps in poliovirus surveillance or reaching elimination with borderline sufficient population immunity could significantly increase the time to reach high confidence about interruption of live poliovirus transmission, such that the path taken to achieve and maintain poliovirus elimination matters. Pakistan and Afghanistan will need to sustain high-quality surveillance for polioviruses after apparent interruption of transmission and recognize that as efforts to identify cases or circulating live polioviruses decrease, the risks of undetected circulation increase and significantly delay the global polio endgame.

Indexed as

AfghanistanCommunicable Disease ControlDisease EradicationGlobal HealthHumansModels, TheoreticalPakistanPoliomyelitisPoliovirusPoliovirus Vaccine, OralRisk AssessmentRisk ManagementVaccinationPoliovirus Vaccine, OralDisease eradicationdisease outbreaksdisease surveillanceenvironmental surveillanceinfection transmission modelingpoliomyelitispoliovirusvaccination

Identifiers

PMID30296340
PMCPMC7842182
OpenAlexW2897410021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.